The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Prevalence of lysosomal storage disorders
Meikle, P. J. (1999) · JAMA · doi:10.1001/jama.281.3.249 · Cited by 2,197
Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
Eng, C. M., Guffon, N., Wilcox, W. R., Germain, D. P., Lee, P., Waldek, S., Caplan, L., Linthorst, G. E., & Desnick, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450102 · Cited by 1,559
Self-citationEnzyme Replacement Therapy in Fabry Disease: A Randomized Controlled Trial
Schiffmann, R., Kopp, J. B., Austin III, H. A., Sabnis, S., Moore, D. F., Weibel, T., Balow, J. E., & Brady, R. O. (2001) · JAMA · doi:10.1001/jama.285.21.2743 · Cited by 1,302
Desnick, R. J., Brady, R., Barranger, J., Collins, A. J., Germain, D. P., Goldman, M., Grabowski, G., Packman, S., & Wilcox, W. R. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-4-200302180-00014 · Cited by 766
Self-citationAn Atypical Variant of Fabry's Disease in Men with Left Ventricular Hypertrophy
Nakao, S., Takenaka, T., Maeda, M., Kodama, C., Tanaka, A., Tahara, M., Yoshida, A., Kuriyama, M., Hayashibe, H., Sakuraba, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330504 · Cited by 763
Self-citationScreening Newborns for Inborn Errors of Metabolism by Tandem Mass Spectrometry
Wilcken, B., Wiley, V., Hammond, J., & Carpenter, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025225 · Cited by 677
Fan, J.-Q., Ishii, S., Asano, N., & Suzuki, Y. (1999) · Nature Medicine · doi:10.1038/4801 · Cited by 614
α-Galactosidase A deficiency. Fabry disease
Desnick, R. J. (2001) · Cited by 605
Self-citationPrevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy
Sachdev, B., Takenaka, T., Teraguchi, H., Tei, C., Lee, P., McKenna, W. J., & Elliott, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000012626.81324.38 · Cited by 570
Schulze, A., Lindner, M., Kohlmüller, D., Olgemöller, K., Mayatepek, E., & Hoffmann, G. F. (2003) · Pediatrics · doi:10.1542/peds.111.6.1399 · Cited by 519
SAFETY AND EFFICACY OF RECOMBINANT HUMAN a -GALACTOSIDASE A REPLACEMENT THERAPY IN FABRY'S DISEASE
Ng, M., Uffon, N. A. G., Ilcox, W. I. R. W., Ermain, P. G., Ee, P., Aldek, S. T. W., Aplan, L. O. C., Inthorst, E. L., & Esnick, R. O. J. D. (2001) · Cited by 482
Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study
Rolfs, A., Böttcher, T., Zschiesche, M., Morris, P., Winchester, B., Bauer, P., Walter, U., Mix, E., Löhr, M., Harzer, K., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67635-0 · Cited by 464
Laboratory standards and guidelines for population-based cystic fibrosis carrier screening
Grody, W. W., Cutting, G. R., Klinger, K. W., Richards, C. S., Watson, M. S., & Desnick, R. J. (2001) · Genetics in Medicine · doi:10.1097/00125817-200103000-00010 · Cited by 456
Self-citationNakao, S., Kodama, C., Takenaka, T., Tanaka, A., Yasumoto, Y., Yoshida, A., Kanzaki, T., Enriquez, A. L. D., Eng, C. M., Tanaka, H., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00160.x · Cited by 436
Self-citationLong-Term Safety and Efficacy of Enzyme Replacement Therapyfor Fabry Disease
Wilcox, W. R., for the International Fabry Disease Study Group, Banikazemi, M., Guffon, N., Waldek, S., Lee, P., Linthorst, G. E., Desnick, R. J., & Germain, D. P. (2004) · The American Journal of Human Genetics · doi:10.1086/422366 · Cited by 404
Self-citationThe Molecular Defect Leading to Fabry Disease: Structure of Human α-Galactosidase
Garman, S. C., & Garboczi, D. N. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.01.035 · Cited by 399
Fabry, J. (1898) · Archiv für Dermatologie und Syphilis · doi:10.1007/bf01986897 · Cited by 374
An Atypical Variant of Fabry's Disease with Manifestations Confined to the Myocardium
Scheidt, W. V., Eng, C. M., Fitzmaurice, T. F., Erdmann, E., Hübner, G., Olsen, E. G. J., Christomanou, H., Kandolf, R., Bishop, D. F., & Desnick, R. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102073240607 · Cited by 371
Self-citationDirect Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn Screening
Li, Y., Scott, C. R., Chamoles, N. A., Ghavami, A., Pinto, B. M., Turecek, F., & Gelb, M. H. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.035907 · Cited by 332
Frustaci, A., Chimenti, C., Ricci, R., Natale, L., Russo, M. A., Pieroni, M., Eng, C. M., & Desnick, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450104 · Cited by 332
Self-citationANDERSON, W. (1898) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1898.tb16317.x · Cited by 326
Desnick, R. J., Allen, K. Y., Desnick, S. J., Raman, M. K., Bernlohr, R. W., & Krivit, W. A. (1973) · PubMed · Cited by 304
Self-citationEnzyme replacement and enhancement therapies: lessons from lysosomal disorders
Desnick, R. J., & Schuchman, E. H. (2002) · Nature Reviews Genetics · doi:10.1038/nrg963 · Cited by 268
Self-citationA contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity
Fan, J.-Q. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00158-5 · Cited by 232
Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease.
Eng, C. M., Resnick‐Silverman, L., Niehaus, D. J., Astrin, K. H., & Desnick, R. J. (1993) · PubMed · Cited by 220
Self-citationResults of a Nationwide Screening for Anderson-Fabry Disease among Dialysis Patients
Kotanko, P., Kramar, R., Devrnja, D., Paschke, E., Voigtla[Combining Diaeresis]nder, T., Auinger, M., Demmelbauer, K., Lorenz, M., Hauser, A.-C., Kofler, H.-J. D., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000124671.61963.1e · Cited by 199
Froissart, R. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00136-7 · Cited by 128
Newborn Screening for Lysosomal Storage Disorders: Clinical Evaluation of a Two-Tier Strategy
Meikle, P. J., Ranieri, E., Simonsen, H., Rozaklis, T., Ramsay, S. L., Whitfield, P. D., Fuller, M., Christensen, E., Skovby, F., & Hopwood, J. J. (2004) · PEDIATRICS · doi:10.1542/peds.2004-0583 · Cited by 110
Galactose Stabilizes Various Missense Mutants of α-Galactosidase in Fabry Disease
Okumiya, T., Ishii, S., Takenaka, T., Kase, R., Kamei, S., Sakuraba, H., & Suzuki, Y. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2416 · Cited by 101
Self-citationLysosomal storage disorders: emerging therapeutic options require early diagnosis
Meikle, P. J., & Hopwood, J. J. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-003-1348-y · Cited by 72
Treatment of carnitine deficiency
Winter, S. C. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1024433100257 · Cited by 60
Matsuzawa, F., Aikawa, S., Doi, H., Okumiya, T., & Sakuraba, H. (2005) · Human Genetics · doi:10.1007/s00439-005-1300-5 · Cited by 55
Self-citationSakuraba, H., Eng, C. M., Desnick, R. J., & Bishop, D. F. (1992) · Genomics · doi:10.1016/0888-7543(92)90288-4 · Cited by 48
Self-citationGENETIC SCREENING: Carriers and Affected Individuals
McCabe, L. L., & McCabe, E. R. B. (2004) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.5.061903.175941 · Cited by 30
Cited by
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,104
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Germain, D. P. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-30 · Cited by 1,198
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e230 · Cited by 818
Zarate, Y. A., & Hopkin, R. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61589-5 · Cited by 795
Metadata
- Authors
- Spada, M., Pagliardini, S., Yasuda, M., Tukel, T., Thiagarajan, G., Sakuraba, H., Ponzone, A., & Desnick, R. J.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 79
- Issue
- 1
- Pages
- 31-40
- ISSN
- 0002-9297 (ISSN-L)
- OpenAlex
- W2042609729
- Cited by
- 1,008
- References
- 36
- FWCI
- 19.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.